Fibroblast independency in tumors: Implications in cancer therapy

Future Oncology

Volumn 4, Issue 3, 2008, Pages 427-432

  Tsellou, Erasmia ^a   Kiaris, Hippokraktis ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Autonomy; Fibroblasts; Stroma; Therapy

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53; PROTEIN TYROSINE KINASE INHIBITOR;

BREAST CANCER; CANCER CELL; CANCER GENETICS; CANCER GROWTH; CANCER INHIBITION; CANCER STAGING; CANCER THERAPY; CARCINOGENESIS; CELL GROWTH; CELL ISOLATION; DRUG EFFICACY; DRUG TARGETING; FIBROBLAST; GENE ACTIVATION; GENE EXPRESSION PROFILING; GENE MUTATION; GROWTH REGULATION; HUMAN; IMMUNE RESPONSE; LYMPH NODE METASTASIS; LYMPHOCYTE; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; METASTASIS POTENTIAL; NONHUMAN; PRECANCER; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STROMA CELL; TUMOR SUPPRESSOR GENE;

ANIMALS; FIBROBLASTS; HUMANS; NEOPLASMS; STROMAL CELLS; T-LYMPHOCYTES;

EID: 47249136922     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/14796694.4.3.427     Document Type: Review

References (21)

1. Kalluri R, Zeisberg M: Fibroblasts in cancer. Nat Rev. Cancer 6, 392-401 (2006).
2. Kurose K, Gilley K, Matsumoto S, Watson PH, Zhou XP, Eng C: Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas. Nat. Cenet. 32, 355-357 (2002).
3. Fukino K, Shen L, Matsumoto S, Morrison CD, Mutter GL, Eng C: Combined total genome loss of heterozygosity scan of breast cancer stroma and epithelium reveals multiplicity of stromal targets. Cancer Res. 64, 7231-7236 (2004).
4. Moinfar F, Man YC, Arnould L, Bratthauer GL, Ratschek M, Tavassoli FA: Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: Implications for tumorigenesis. Cancer Res. 60, 2562-2566 (2000).
5. Patocs A, Zhang L, Xu Y et al.: Breast-cancer stromal cells with TP53 mutations and nodal metastases. N. Engl. J. Med. 357, 2543-2551 (2007).
6. Lewis MP, Lygoe KA, Nystrom ML et al.: Tumour-derived TGF-β1 modulates myofibroblast differentiation and promotes HGF/SF-dependent invasion of squamous carcinoma cells. Br. J. Cancer 90, 822-832 (2004).
7. Ao M, Franco OE, Park D, Raman D, Williams K, Hayward SW. Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium. Cancer Res. 67, 4244-4253 (2007).
8. De Wever O, Nguyen QD, Van Hoorde L et al.: Tenascin-C and SF/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac. FASEB J. 18, 1016-1018 (2004).
9. Lynch CC, Matrisian LM: Matrix, metalloproteinases in tumor-host cell communication. Differentiation 70, 561-573 (2002).
10. Kuperwasser C, Chavarria T, Wu M et al.: Reconstruction of functionally normal and malignant human breast tissues in mice. Proc. Natl Acad. Sci. USA 101, 4966-4971 (2004).
11. Kiaris H, Chatzistamou I, Trimis G, Frangou-Plemmenou M, Pafiti-Kondi A, Kalofoutis A: Evidence for nonautonomous effect of p53 tumor suppressor in carcinogenesis. Cancer Res. 65, 1627-1630 (2005).
12. Bhowmick NA, Chytil A, Plieth D et al.: TGF-β signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303, 848-851 (2004).
13. Orimo A, Gupta PB, Sgroi DC et al.: Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121, 335-348 (2005).
14. Elenbaas B, Weinberg RA: Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp. Cell Res. 264, 169-184 (2001).
15. Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tisty TD, Cunha GR: Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res. 59, 5002-5011 (1999).
16. Cunha GR, Hayward SW, Wang YZ, Ficke WA: Role of the stromal microenvironment in carcinogenesis of the prostate. Int. J. Cancer 107, 1-10 (2003).
17. Skobe M, Fusenig NE: Tumorigenic conversion of immortal human keratinocytes through stromal cell activation. Proc. Natl Acad. Sci. USA 95, 1050-1055 (1998).
18. Lafkas D, Trimis G, Papavassiliou AG, Kiaris H: p53 mutations in stromal fibroblasts sensitize tumors against chemotherapy. Int. J. Cancer (2008) (In press).
19. Uchida D, Onoue T, Tomizuka Y et al.: Involvement of an autocrine stromal cell derived factor-1/CXCR4 system on the distant metastasis of human oral squamous cell carcinoma. Mol. Cancer Res. 5, 685-694 (2007).
20. Pan J, Mestas J, Burdick MD et al.: Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis. Mol. Cancer 5, 56 (2006).
21. Yang YC, Lee ZY, Wu CC, Chen TC, Chang CL, Chen CP: CXCR4 expression is associated with pelvic lymph node metastasis in cervical adenocarcinoma. Int. Gynecol. Cancer 17, 676-686 (2007).